KCNN4 and central nervous system cancer: We have previously shown that KCa3.1 inhibition reduced astrogliosis and microglia activation in glioma bearing mice [11] and reduces microglia activation and infarct size, increasing neuronal survival in a mouse model of ischemic stroke [26].